FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 140 filers reported holding FATE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 319 | -96.6% | 0.00% | – |
Q2 2023 | $44 | -24.1% | 9,441 | -8.7% | 0.00% | – |
Q1 2023 | $58 | +286.7% | 10,336 | +587.2% | 0.00% | – |
Q4 2022 | $15 | -100.0% | 1,504 | +10.2% | 0.00% | – |
Q3 2022 | $30,000 | +650.0% | 1,365 | +689.0% | 0.00% | – |
Q2 2022 | $4,000 | -99.0% | 173 | -98.3% | 0.00% | – |
Q1 2022 | $403,000 | +1579.2% | 10,417 | +2345.3% | 0.00% | – |
Q4 2021 | $24,000 | -96.9% | 426 | -97.8% | 0.00% | -100.0% |
Q3 2020 | $770,000 | +2466.7% | 19,284 | +1121.3% | 0.00% | – |
Q4 2019 | $30,000 | -81.4% | 1,579 | -84.8% | 0.00% | – |
Q3 2019 | $161,000 | -25.8% | 10,388 | -3.2% | 0.00% | -100.0% |
Q2 2019 | $217,000 | -32.8% | 10,730 | -41.7% | 0.00% | 0.0% |
Q1 2019 | $323,000 | +201.9% | 18,413 | +119.4% | 0.00% | – |
Q4 2018 | $107,000 | +10600.0% | 8,394 | +7263.2% | 0.00% | – |
Q3 2018 | $1,000 | -99.3% | 114 | -99.1% | 0.00% | -100.0% |
Q2 2018 | $149,000 | -48.1% | 13,165 | -55.3% | 0.00% | -92.3% |
Q1 2018 | $287,000 | +1095.8% | 29,462 | +637.7% | 0.01% | +1200.0% |
Q4 2017 | $24,000 | – | 3,994 | +3740.4% | 0.00% | – |
Q3 2017 | $0 | – | 104 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |